Article info

Download PDFPDF
Concise report
Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study

Authors

  1. Correspondence to Professor Joachim Sieper, Medical Department I, Rheumatology, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, Berlin 12203, Germany; joachim.sieper{at}charite.de
View Full Text

Citation

Sieper J, Deodhar A, Marzo-Ortega H on behalf of the MEASURE 2 Study Group, et al
Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study

Publication history

  • Received June 6, 2016
  • Revised August 3, 2016
  • Accepted August 9, 2016
  • First published August 31, 2016.
Online issue publication 
February 17, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.